Allena Pharmaceuticals is focused on treating complex metabolic conditions that can lead to significant and costly health complications. The Company aims to reduce the burden of toxic metabolites such as oxalate and uric acid. These metabolites are normal byproducts of cellular activity and are also derived from the typical diet. In certain circumstances, they can build up and lead to complications such as hyperoxaluria and kidney stones (nephrolithiasis) in the case of oxalate, or hyperuricemia and gout in the case of uric acid.
Newton, US
Size (employees)
36 (est)
Allena Pharmaceuticals was founded in 2010 and is headquartered in Newton, US
Report incorrect company information

Key People/Management at Allena Pharmaceuticals

Alexey Margolin

Alexey Margolin

Hugh Wight

Hugh Wight

Vice President of Technical Operations

Allena Pharmaceuticals Office Locations

Allena Pharmaceuticals has an office in Newton
Newton, US (HQ)
One Newton Executive Park, Suite 202
Show all (1)
Report incorrect company information

Allena Pharmaceuticals Financials and Metrics

Summary Metrics

Allena Pharmaceuticals's latest funding round in December 2015 was reported to be $53 m. In total, Allena Pharmaceuticals has raised $93 m
Report incorrect company information